| scholarly article | Q13442814 |
| P2093 | author name string | Jian Lu | |
| Haibo Wang | |||
| Xianqun Fan | |||
| Jianjun Zhang | |||
| He Zhang | |||
| Andrew R Hoffman | |||
| Haiyan Guo | |||
| Shengfang Ge | |||
| Ji-Fan Hu | |||
| Shenglin Huang | |||
| Guanxiang Qian | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 | ||
| Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155. | Q24542505 | ||
| Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
| Identification of mammalian microRNA host genes and transcription units | Q24562298 | ||
| The microRNAs of Caenorhabditis elegans | Q24672515 | ||
| Identification of tissue-specific microRNAs from mouse | Q27860892 | ||
| MicroRNA-directed cleavage of HOXB8 mRNA | Q28131834 | ||
| The Bcl2 family: regulators of the cellular life-or-death switch | Q29614982 | ||
| The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
| Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors | Q33713001 | ||
| Safety and antitumor activity of recombinant soluble Apo2 ligand | Q33855449 | ||
| Human Bcl-2 antisense therapy for lymphomas | Q33916124 | ||
| Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. | Q34156507 | ||
| The potential of TRAIL for cancer chemotherapy | Q34271024 | ||
| Genasense (Genta Inc). | Q34375660 | ||
| Transcription and processing of human microRNA precursors | Q34378218 | ||
| Novel approaches to the treatment of non-small cell lung cancer. | Q34498105 | ||
| Apoptosis: a link between cancer genetics and chemotherapy | Q34520432 | ||
| Role of Bcl-2 family of proteins in malignancy | Q34733047 | ||
| Apoptosis-based therapies | Q34742803 | ||
| Correction of aberrant imprinting of IGF2 in human tumors by nuclear transfer-induced epigenetic reprogramming | Q35130964 | ||
| The role of Bcl-2 family members in tumorigenesis | Q35680535 | ||
| Promoting apoptosis as a strategy for cancer drug discovery | Q36292878 | ||
| Directing DNA methylation to inhibit gene expression | Q36482583 | ||
| Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. | Q37023777 | ||
| Directing cancer cells to self-destruct with pro-apoptotic receptor agonists | Q37319386 | ||
| AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice | Q39981468 | ||
| Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells | Q40330010 | ||
| Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer | Q40486739 | ||
| Small interfering RNA targeting bcl-2 sensitizes malignant melanoma | Q40527363 | ||
| Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer | Q40550050 | ||
| Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. | Q40576657 | ||
| Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. | Q40616262 | ||
| Apoptosis in cancer therapy: crossing the threshold | Q40694262 | ||
| Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. | Q41461017 | ||
| Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. | Q41668626 | ||
| Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL. | Q42278494 | ||
| Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer | Q42457244 | ||
| Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. | Q43696432 | ||
| Why G3139 works poorly in cancer trials but might work well against HIV. | Q44304093 | ||
| Stable suppression of tumorigenicity by virus-mediated RNA interference | Q45730805 | ||
| Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation. | Q45985336 | ||
| Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19. | Q46005770 | ||
| Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis | Q47670151 | ||
| bcl-2 Protein Expression in Cutaneous Malignant Melanoma and Benign Melanocytic Nevi | Q50764553 | ||
| Clinical trials referral resource. Current clinical trials of G3139 | Q53649278 | ||
| Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic β cells by Bcl-2 and X-linked inhibitor of apoptosis | Q57462321 | ||
| Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect | Q64377565 | ||
| High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy | Q72081677 | ||
| A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798) | Q80149334 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 2229-2239 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA | |
| P478 | volume | 126 |
| Q36099255 | Enhanced therapeutic efficacy of vitamin K2 by silencing BCL-2 expression in SMMC-7721 hepatocellular carcinoma cells |
| Q35054432 | Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts |
| Q39756408 | SP1 suppresses phorbol 12-myristate 13-acetate induced up-regulation of human regucalcin expression in liver cancer cells |
| Q39098583 | The role of Bax and Bcl-2 in gemcitabine-mediated cytotoxicity in uveal melanoma cells |
Search more.